CYTENA
Justin Loo has a range of work experience in sales and product specialist roles. Justin is currently working as the Sales Team Lead Biosciences at CYTENA since April 2022. Previously, they worked as a Sales Executive at CELLINK from January 2021 to April 2022. Prior to that, they held the position of Product Specialist at ITS SCIENCE & MEDICAL PTE LTD (HQ) from December 2019 to January 2021. Justin also worked as a Sales Specialist at Merck Group from April 2019 to October 2019. Justin began their career as a Sales Executive at Marubeni Corporation from July 2016 to April 2019. Justin's earliest work experience was as a QA Intern at Pacific Refreshments (Coca-Cola) Pte Ltd from January 2016 to June 2016.
Justin Loo pursued their education in Chemistry and Biochemistry at Nanyang Technological University Singapore from 2012 to 2016.
This person is not in any offices
CYTENA
cytena GmbH has developed a device called cy-Clone to separate single cells. Single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research. The cy-Clone is supported by an automated imaging process to encapsulate cells indroplets, which are delivered to any type of substrate. Thanks to this particularly gentle delivery method, the cells are able to survive post printing and can either be analyzed thereafter or grown into clonal colonies. To determine clonality, multiple images are recorded during the process. Cross-contamination is avoided by the use of disposable parts.